Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More – Xconomy
Xconomy |
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More
Xconomy Xconomy National —. Politics is more partisan than ever these days, but the opioid crisis might be one of the few issues where elected officials find common ground. This week, members of Congress exercised a bipartisan effort in both chambers to … |
STAT |
All you need to know for round 2 of the CRISPR patent fight
STAT The patent office ruled 1 in February 2017 that the Broad’s 2014 CRISPR patent on using CRISPR-Cas9 to edit genomes, based on discoveries 2 by Feng Zhang, did not “interfere” with a patent application by UC based on the work of UC Berkeley’s Jennifer … |
STAT |
All you need to know for round 2 of the CRISPR patent fight
STAT The patent office ruled 1 in February 2017 that the Broad’s 2014 CRISPR patent on using CRISPR-Cas9 to edit genomes, based on discoveries 2 by Feng Zhang, did not “interfere” with a patent application by UC based on the work of UC Berkeley’s Jennifer … |
PharmaTimes |
CAR–T therapy could be available to NHS patients this year
PharmaTimes NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T–cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a ‘ground-breaking’ approach to treating cancer. Addressing the … New CAR–T therapy could provide safer, more effective cancer treatmentNews-Medical.net Risk Versus Reward: The Value of Cell Therapy for Patients and InvestorsMENAFN.COM |
News-Medical.net |
New CAR–T therapy could provide safer, more effective cancer treatment
News-Medical.net There have been few cancer treatments with such a promising future as using the patient’s own immune system. Known as chimeric antigen receptor T–cell therapy, or CAR-T, this treatment uses re-engineered killer T–cells to attack cancer cells, but it … |